ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk (NVO) Raises Sales Outlook for 2023, Shares Gain
Novo Nordisk NVO upped its sales and operating profit forecast for 2023 yet again on the back of higher demand for diabetes drug Ozempic (semaglutide) and obesity drug Wegovy. 
Announcement as on 16 October 2023

: Novo Nordisk boosts sales and profit outlook, buoyed by Ozempic and Wegovy
Novo Nordisk NVO on Friday boosted its full-year 2023 profit and sales outlook, reflecting heightened expectations for Ozempic and Wegovy sales. The company now projects full-year sales growth of 32% to 38%, up from 27% to 33% previously, and operating pro
Announcement as on 13 October 2023

European stocks edge up as Novo Nordisk offsets luxury sector jitters
​European stocks inched higher on Wednesday as Novo Nordisk shares jumped after a positive update on its diabetes drug Ozempic, though underwhelming results from French luxury giant LVMH capped gains.
Announcement as on 11 October 2023

Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats
He urged patients not to buy copycat versions of Wegovy, warning they could be unsafe
Announcement as on 29 September 2023

Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats
Novo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure sufficient supply before entering the Indian market, where obesity rates are high. Counterfeit versions of Wegovy are alr
Announcement as on 29 September 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.7
  • 12Day Average: 38.77
  • 20Day Average: 40.65
  • 50Day Average: 44.46
  • 100Day Average: 45.41
  • 150Day Average: 43.57
  • 200Day Average: 45.65

NVO Indicators & signals

Indicator MACD (12,26,9)

38.97, 41.13, -1.98
Indicator MACD is in negative zone

Indicator ADX (14)

50, 13.79, 41.38
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Mon Oct 2026 37.56 36.46 to 37.76 0.64% 0.64 times
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.61 times
01 Thu Oct 2026 37.41 37.37 to 38.15 -1.32% 0.55 times
30 Wed Sep 2026 37.91 37.89 to 38.77 -1.04% 1.28 times
29 Tue Sep 2026 38.31 38.05 to 38.38 -1.03% 0.56 times
28 Mon Sep 2026 38.71 38.23 to 38.90 -0.21% 0.68 times
25 Fri Sep 2026 38.79 38.41 to 38.88 0.41% 0.45 times
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.87 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.1 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.45 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.44 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.62 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top